Interim buprenorphine treatment in opiate dependence: A pilot effectiveness study

References

• McLellan AT, Lewis DC, O'Brien CP, Kleber HD. Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA. 2000;284:1689–1695.
   PubMed Web of Science ®Google Scholar
• Degenhardt L, Bucello C, Mathers B, et al. Mortality among regular or dependent users of heroin and other opioids: A systematic review and meta-analysis of cohort studies. Addiction. 2011;106:32–51.
   PubMed Web of Science ®Google Scholar
• Goldstein A, Herrera J. Heroin addicts and methadone treatment in Albuquerque: a 22-year follow-up. Drug Alcohol Depend. 1995;40:139–150.
   PubMed Web of Science ®Google Scholar
• Hulse GK, English DR, Milne E, Holman CD. The quantification of mortality resulting from the regular use of illicit opiates. Addiction. 1999;94:221–229.
   PubMed Web of Science ®Google Scholar
• Gronbladh L, Ohlund LS, Gunne LM. Mortality in heroin addiction: impact of methadone treatment. Acta Psychiatr Scand. 1990;82:223–227.
   PubMed Web of Science ®Google Scholar
• Mattick RP, Kimber J, Breen C, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev. 2008;(2):CD002207.
   PubMed Web of Science ®Google Scholar
• Fugelstad A, Stenbacka M, Leifman A, Nylander M, Thiblin I. Methadone maintenance treatment: the balance between life-saving treatment and fatal poisonings. Addiction. 2007;102:406–412.
   PubMed Web of Science ®Google Scholar
• Vormfelde SV, Poser W. Death attributed to methadone. Pharmacopsychiatry. 2001;34:217–222.
   PubMed Web of Science ®Google Scholar
• Robinson SE. Buprenorphine: an analgesic with an expanding role in the treatment of opioid addiction. CNS Drug Rev. 2002;8:377–390.
   PubMedGoogle Scholar
• Gunderson EW, Fiellin DA. Office-based maintenance treatment of opioid dependence: how does it compare with traditional approaches? CNS Drugs. 2008;22:99–111.
   PubMed Web of Science ®Google Scholar
• Gibson AE, Doran CM, Bell JR, Ryan A, Lintzeris N. A comparison of buprenorphine treatment in clinic and primary care settings: a randomised trial. Med J Aust. 2003;179:38–42.
   PubMed Web of Science ®Google Scholar
• European Monitoring Centre for Drugs and Drug Addiction. Annual Report 2012: The State of the Drugs Problem in Europe. Luxembourg: Publications Office of the European Union; 2012.
   Google Scholar
• Sigmon SC. Access to treatment for opioid dependence in rural America: challenges and future directions. JAMA Psychiatry. 2014;71:359–360.
   PubMed Web of Science ®Google Scholar
• Schwartz RP, Jaffe JH, Highfield DA, Callaman JM, O'Grady KE. A randomized controlled trial of interim methadone maintenance: 10-month follow-up. Drug Alcohol Depend. 2007;86:30–36.
   PubMed Web of Science ®Google Scholar
• Yancovitz SR, Des Jarlais DC, Peyser NP, et al. A randomized trial of an interim methadone maintenance clinic. Am J Public Health. 1991;81:1185–1191.
   PubMed Web of Science ®Google Scholar
• Schwartz RP, Kelly SM, O'Grady KE, Gandhi D, Jaffe JH. Interim methadone treatment compared to standard methadone treatment: 4-month findings. J Subst Abuse Treat. 2011;41:21–29.
   PubMed Web of Science ®Google Scholar
• Krook AL, Brors O, Dahlberg J, et al. A placebo-controlled study of high dose buprenorphine in opiate dependents waiting for medication-assisted rehabilitation in Oslo, Norway. Addiction. 2002;97:533–542.
   PubMed Web of Science ®Google Scholar
• The National Board of Health and Welfare (Socialstyrelsen). Socialstyrelsens föreskrifter och allmänna råd om läkemedelsassisterad behandling vid opiatberoende [The Board's provisions and general guidelines on medication-assisted treatment in opiate dependence]. SOSFS 2009:27 ed. Västerås, Sweden: The National Board of Health and Welfare; 2009.
   Google Scholar
• European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Legal frameworks of opioid substitution treatment. Available at: http://www.emcdda.europa.eu/html.cfm/index41823EN.html. Published 2008. Accessed 2015.
   Google Scholar
• Romelsjo A, Engdahl B, Stenbacka M, et al. Were the changes to Sweden's maintenance treatment policy 2000–06 related to changes in opiate-related mortality and morbidity? Addiction. 2010;105:1625–1632.
   PubMed Web of Science ®Google Scholar
• The National Board of Health and Welfare (Socialstyrelsen). Kartläggning av läkemedelsassisterad behandling vid opiatberoende [Survey of medication-assisted treatment in opiate dependence]. Västerås, Sweden: The National Board of Health and Welfare (Socialstyrelsen); 2012.
   Google Scholar
• McLellan AT, Kushner H, Metzger D, et al. The Fifth Edition of the Addiction Severity Index. J Subst Abuse Treat. 1992;9:199–213.
   PubMed Web of Science ®Google Scholar
• Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption—II. Addiction. 1993;88:791–804.
   PubMed Web of Science ®Google Scholar
• Hakansson A, Medvedeo A, Andersson M, Berglund M. Buprenorphine misuse among heroin and amphetamine users in Malmo, Sweden: purpose of misuse and route of administration. Eur Addict Res. 2007;13:207–215.
   PubMed Web of Science ®Google Scholar
• Kamal F, Flavin S, Campbell F, Behan C, Fagan J, Smyth R. Factors affecting the outcome of methadone maintenance treatment in opiate dependence. Irish Med J. 2007;100:393–397.
   PubMedGoogle Scholar
• Ohlin L, Hesse M, Fridell M, Tatting P. Poly-substance use and antisocial personality traits at admission predict cumulative retention in a buprenorphine programme with mandatory work and high compliance profile. BMC Psychiatry. 2011;11:81.
   PubMed Web of Science ®Google Scholar
• Somers CJ, O'Connor J. Retrospective study of outcomes, for patients admitted to a drug treatment centre board. Irish Med J. 2012;105:295–298.
   PubMedGoogle Scholar
• Stenbacka M, Beck O, Leifman A, Romelsjo A, Helander A. Problem drinking in relation to treatment outcome among opiate addicts in methadone maintenance treatment. Drug Alcohol Rev. 2007;26:55–63.
   PubMed Web of Science ®Google Scholar
• Jones JD, Mogali S, Comer SD. Polydrug abuse: a review of opioid and benzodiazepine combination use. Drug Alcohol Depend. 2012;125:8–18.
   PubMed Web of Science ®Google Scholar
• Lintzeris N, Nielsen S. Benzodiazepines, methadone and buprenorphine: interactions and clinical management. Am J Addict. 2010;19:59–72.
   PubMed Web of Science ®Google Scholar